SCHEDULE 13G
0001802528
XXXXXXXX
LIVE
Common Stock, par value $0.001 per share
12/11/2024
0001370053
ANAPTYSBIO, INC
032724106
10770 Wateridge Circle, Suite 210
San Diego
CA
92121
Rule 13d-1(c)
Fairmount Funds Management LLC
DE
0.00
1671484.00
0.00
1671484.00
1671484.00
N
5.5
IA
The percentage calculation is based upon 30,428,682 shares of the Issuer's Common Stock outstanding as of October 31, 2024, as disclosed in the Form 10-Q filed by the Issuer with the Securities and Exchange Commission on November 5, 2024.
Fairmount Healthcare Fund II L.P.
DE
0.00
1671484.00
0.00
1671484.00
1671484.00
N
5.5
PN
The percentage calculation is based upon 30,428,682 shares of the Issuer's Common Stock outstanding as of October 31, 2024, as disclosed in the Form 10-Q filed by the Issuer with the Securities and Exchange Commission on November 5, 2024.
Peter Harwin
X1
0.00
1671484.00
0.00
1671484.00
1671484.00
N
5.5
HC
IN
The percentage calculation is based upon 30,428,682 shares of the Issuer's Common Stock outstanding as of October 31, 2024, as disclosed in the Form 10-Q filed by the Issuer with the Securities and Exchange Commission on November 5, 2024.
Tomas Kiselak
2B
0.00
1671484.00
0.00
1671484.00
1671484.00
N
5.5
HC
IN
The percentage calculation based upon 30,428,682 shares of the Issuer's Common Stock outstanding as of October 31, 2024, as disclosed in the Form 10-Q filed by the Issuer with the Securities and Exchange Commission on November 5, 2024.
ANAPTYSBIO, INC
10770 Wateridge Circle, Suite 210 San Diego, CA, 92121
This joint statement on Schedule 13G (this 'Statement') is being filed by Fairmount Funds Management LLC ('Fairmount'), Fairmount Healthcare Fund II L.P. ('Fund II'), Peter Harwin, and Tomas Kiselak. Fairmount, Fund II, Mr. Harwin, and Mr. Kiselak are collectively referred to herein as the 'Reporting Persons.'
The Common Stock reported herein includes Common Stock beneficially owned directly by Fund II. Fairmount Healthcare Fund II GP LLC is the general partner of Fund II. The controlling persons of Fairmount are Mr. Harwin and Mr. Kiselak. Fairmount serves as investment adviser for Fund II and may be deemed a beneficial owner, for purposes of Section 13(d) of the Securities Exchange Act of 1934 (the 'Act'), of any securities of the Issuer held by Fund II. Fund II has delegated to Fairmount the sole power to vote and the sole power to dispose of all securities held in Fund II's portfolio, including the shares of the Issuer's Common Stock reported herein. Because Fund II has divested voting and investment power over the reported securities and cannot revoke such delegation on less than 61 days' notice, Fund II disclaims beneficial ownership of the securities for purposes of Section 13(d) of the Act and therefore disclaims any obligation to report ownership of the reported securities under Section 13(d) of the Act. As managing members of Fairmount, Mr. Harwin and Mr. Kiselak may be deemed beneficial owners, for purposes of Section 13(d) of the Act, of any securities of the Issuer beneficially owned by Fairmount. Fairmount, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of the securities reported in this Statement other than for the purpose of determining their obligations under Section 13(d) of the Act, and the filing of the Statement shall not be deemed an admission that any of Fairmount, Mr. Harwin, or Mr. Kiselak is the beneficial owner of such securities for any other purpose.
c/o Fairmount Funds Management LLC, 200 Barr Harbor Drive, Suite 400, West Conshohocken, PA 19428.
Fairmount is a Delaware limited liability company. Fund II is a Delaware limited partnership. Mr. Harwin is a United States citizen. Mr. Kiselak is a Slovak Republic citizen.
Y
See the response(s) to Item 9 on the attached cover page(s).
See the response(s) to Item 11 on the attached cover page(s).
See the response(s) to Item 5 on the attached cover page(s).
See the response(s) to Item 6 on the attached cover page(s).
See the response(s) to Item 7 on the attached cover page(s).
See the response(s) to Item 8 on the attached cover page(s).
Y
Y
Y
Y
Y
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
Exhibit A
Joint Filing Agreement
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned and each other person executing this joint filing agreement (this 'Agreement') agree as follows:
(i) The undersigned and each other person executing this Agreement are individually eligible to use the Schedule 13G to which this Exhibit is attached and such Schedule 13G is filed on behalf of the undersigned and each other person executing this Agreement; and
(ii) The undersigned and each other person executing this Agreement are responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of the undersigned or any other person executing this Agreement is responsible for the completeness or accuracy of the information statement concerning any other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all of which, taken together, shall constitute one and the same instrument.
Dated: December 18, 2024
FAIRMOUNT FUNDS MANAGEMENT LLC
By: /s/ Peter Harwin /s/Tomas Kiselak
Name: Peter Harwin Tomas Kiselak
Title: Managing Member Managing Member
FAIRMOUNT HEALTHCARE FUND II L.P.
By: Fairmount Healthcare Fund II GP LLC
By: /s/ Peter Harwin /s/ Tomas Kiselak
Name: Peter Harwin Tomas Kiselak
Title: Member Member
PETER HARWIN
By: /s/ Peter Harwin
TOMAS KISELAK
By: /s/ Tomas Kiselak
Fairmount Funds Management LLC
/s/ Peter Harwin
12/18/2024
/s/ Tomas Kiselak
12/18/2024
Fairmount Healthcare Fund II L.P.
/s/ Peter Harwin
12/18/2024
/s/ Tomas Kiselak
12/18/2024
Peter Harwin
/s/ Peter Harwin
12/18/2024
Tomas Kiselak
/s/ Tomas Kiselak
12/18/2024